Clinical research of endocrine resistance in breast cancer / 国际肿瘤学杂志
Journal of International Oncology
; (12): 509-511, 2013.
Article
en Zh
| WPRIM
| ID: wpr-438730
Biblioteca responsable:
WPRO
ABSTRACT
Endocrine therapy is the most important systemic therapy for hormone receptor positive breast cancer.However,intrinsic or acquired resistance to endocrine therapy is a challenge currently.Crosstalk between estrogen receptor pathway and other pathway is considered to be one of the underlying mechanisms.Progress has been made in reversing resistance by blocking signaling through pathways such as the phosphoinositide 3-kinasesprotein kinase B-mammalian target of rapamycin and epidermal growth factor receptor pathway.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Journal of International Oncology
Año:
2013
Tipo del documento:
Article